Skip to main content

Advertisement

SpringerLink
Log in

The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Hyperlipidemia is a major risk factor for coronary artery disease (CAD). Lipoprotein lipase (LPL) is an important enzyme in lipoprotein metabolism. S447X polymorphism of the LPL gene has been implicated in the pathogenesis of CAD. Carriers of X447 allele were reported to have lower triglyceride and higher high-density lipoprotein cholesterol levels as well as a reduced risk of CAD. We hypothesized that S447X gene polymorphism might have a protective effect for CAD. A total of 178 subjects (mean age 42.97 ± 6.5 years) who underwent coronary angiography for clinical indications were included in the study. The patients had been referred for evaluation of chest pain and/or abnormal stress tests, and were selected consecutively. Gensini scores were used to assess the severity of CAD; 97 patients were diagnosed with angiographically proven CAD, and 81 subjects did not display significant CAD (≥70%) angiographically. Genotyping of LPL S447X polymorphism was performed by real-time polymerase chain reaction amplification and fluorescent probe melting point analysis on the light cycler. The minor allele frequencies of LPL 447X allele were 11.1% and 6.2% among subjects without CAD compared with CAD subjects (P = 0.081) and 447X allele had favorable effects on lipid levels among CAD patients; 447X homozygotes and heterozygotes displayed lower total cholesterol (171 ± 37 vs 208 ± 48 mg/dl, P = 0.02), lower triglycerides (121 ± 72 vs 184 ± 86 mg/dl, P = 0.02), lower low-density lipoprotein cholesterol (102 ± 27 vs 129 ± 39 mg/dl, P = 0.03). Gensini scores were significantly lower among the heterozygotes and homozygotes of LPL 447X allele than in the LPL S447 homozygotes (15 ± 23 vs 25 ± 30, P = 0.048). S447X polymorphism of LPL gene may have a protective role for the severity of CAD. The beneficial effects of S447X polymorphism of the LPL gene may be through its favorable effects on lipid levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil 14(Supp 2):E1–E40

    Google Scholar 

  2. Wang H, Eckel RH (2009) Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297:E271–E288

    Article  PubMed  CAS  Google Scholar 

  3. Kobayashi J, Nohara A, Kawashiri MA, Inazu A, Koizumi J, Nakajima K, Mabuchi H (2007) Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta 378:7–12

    Article  PubMed  CAS  Google Scholar 

  4. Kobayashi J, Saito K, Fukamachi I, Taira K, Takahashi K, Bujo H, Saito Y (2001) Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation. Horm Metab Res 33:412–416

    Article  PubMed  CAS  Google Scholar 

  5. Dugi KA, Schmidt N, Brandauer K, Ramacher D, Fiehn W, Kreuzer J (2002) Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease. Atherosclerosis 163:127–134

    Article  PubMed  CAS  Google Scholar 

  6. Fisher RM, Humphries SE, Talmud PJ (1997) Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145–159

    Article  PubMed  CAS  Google Scholar 

  7. Murthy V, Julien P, Gagne C (1996) Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 70:101–135

    Article  PubMed  CAS  Google Scholar 

  8. Stein Y, Stein O (2003) Lipoprotein lipase and atherosclerosis. Atherosclerosis 170:1–9

    Article  PubMed  CAS  Google Scholar 

  9. Evans V, Kastelein JJ (2002) Lipoprotein lipase deficiency—rare or common? Cardiovasc Drugs Ther 16:283–287

    Article  PubMed  CAS  Google Scholar 

  10. Merkel M, Eckel RH, Goldberg IJ (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997–2006

    Article  PubMed  CAS  Google Scholar 

  11. Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ, Stroes ES, Kuivenhoven JA (2006) Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 26:1236–1245

    Article  PubMed  CAS  Google Scholar 

  12. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG (1999) Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901–2907

    PubMed  CAS  Google Scholar 

  13. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ (1998) Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18:526–534

    Article  PubMed  CAS  Google Scholar 

  14. Henderson HE, Kastelein JJ, Zwinderman AH, Gagné E, Jukema JW, Reymer PW, Groenemeyer BE, Lie KI, Bruschke AV, Hayden MR, Jansen H (1999) Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 40:735–743

    PubMed  CAS  Google Scholar 

  15. Gagné SE, Larson MG, Pimstone SN, Schaefer EJ, Kastelein JJ, Wilson PW, Ordovas JM, Hayden MR (1999) A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 55:450–454

    Article  PubMed  Google Scholar 

  16. Groenemeijer BE, Hallman MD, Reymer PW, Gagné E, Kuivenhoven JA, Bruin T, Jansen H, Lie KI, Bruschke AV, Boerwinkle E, Hayden MR, Kastelein JJ (1997) Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95:2628–2635

    PubMed  CAS  Google Scholar 

  17. Nikitin AG, Chistiakov DA, Minushkina LO, Zateyshchikov DA, Nosikov VV (2010) Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Heart Vessels 25:229–236

    Article  PubMed  Google Scholar 

  18. Kömürcü-Bayrak E, Onat A, Poda M, Humphries SE, Acharya J, Hergenç G, Çoban N, Can G, Erginel Ünaltuna N (2007) The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. Clin Chim Acta 383:110–115

    Article  PubMed  Google Scholar 

  19. Alper AT, Hasdemir H, Şahin S, Öntürk E, Akyol A, Nurkalem Z, Çakmak N, Erdinler I, Gürkan K (2008) The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Arch Turk Soc Cardiol 36:376–381

    Google Scholar 

  20. Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486–2497

    Article  Google Scholar 

  21. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606

    Article  PubMed  CAS  Google Scholar 

  22. Corella D, Guillen M, Saiz C, Portoles O, Sabater A, Folch J, Ordovas JM (2002) Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. J Lipid Res 43:416–427

    PubMed  CAS  Google Scholar 

  23. Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A (2002) Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165:119–126

    Article  PubMed  CAS  Google Scholar 

  24. Razzaghi H, Aston CE, Hamman RF, Kamboh MI (2000) Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107:257–267

    Article  PubMed  CAS  Google Scholar 

  25. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Nagamachi K, Samukawa M (2010) Distribution of coronary atherosclerosis in patients with coronary artery disease. Heart Vessels 25:14–18

    Article  PubMed  Google Scholar 

  26. Ishio N, Kobayashi Y, Iwata Y, Kitahara H, Fukushima K, Asano T, Nakayama T, Kuroda N, Komuro I (2010) Ubiquitous atherosclerosis in coronary arteries without angiographically significant stenosis. Heart Vessels 25:35–40

    Article  PubMed  Google Scholar 

  27. Burchardt P, Nowak W, Gozdzicka-Jozefiak A, Link R, Grotowski T, Wisniecka A, Siminiak T (2009) Presence of irregularity in region between −1115 and −784 nt in P1 promoter of Insulin-Like Growth Factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data. Heart Vessels 24:254–259

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study is funded by the Scientific Research and Projects Commission of Marmara University (BAPKO SAG-C-TUP-061207-0216).

Author information

Authors and Affiliations

  1. Department of Cardiology, Marmara University Medical School, Istanbul, Turkey

    Mehmet Agirbasli & Mutlu Cagan Sumerkan

  2. Molecular Biology Laboratory of Gastroenterology Institute, Marmara University Medical School, Istanbul, Turkey

    Fatih Eren

  3. Department of Medical Biology, Acıbadem University Medical School, Istanbul, Turkey

    Deniz Agirbasli

  4. Ahmet Mithat Efendi Cad. Akgun Apt. 7/6, Fenerbahce, Kadikoy, Istanbul, 34726, Turkey

    Mehmet Agirbasli

Authors
  1. Mehmet Agirbasli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mutlu Cagan Sumerkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatih Eren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deniz Agirbasli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Agirbasli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agirbasli, M., Sumerkan, M.C., Eren, F. et al. The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease. Heart Vessels 26, 457–463 (2011). https://doi.org/10.1007/s00380-010-0077-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-010-0077-1

Keywords

Search

Navigation